FDA Panel Recommends Enhanced Diversity in Pulse Oximeter Trials to Address Accuracy Disparities
FDA advisory panel suggests more inclusive clinical trials for pulse oximeters, addressing concerns about accuracy variations across different skin tones.
© Copyright 2025. All Rights Reserved by MedPath